These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39333254)

  • 1. Comprehensive analysis of the potential biological significance of CCL5 in pan-cancer prognosis and immunotherapy.
    Shan J; Xu Y; Lun Y
    Sci Rep; 2024 Sep; 14(1):22138. PubMed ID: 39333254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
    Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
    Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412
    [No Abstract]   [Full Text] [Related]  

  • 3. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
    Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
    Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker.
    Zhang D; Liang P; Xia B; Wu J; Hu X
    BMC Cancer; 2024 Aug; 24(1):987. PubMed ID: 39123194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
    Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
    Front Immunol; 2021; 12():734646. PubMed ID: 34795663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TUBA1C orchestrates the immunosuppressive tumor microenvironment and resistance to immune checkpoint blockade in clear cell renal cell carcinoma.
    Li J; Chen M; Tong M; Cao Q
    Front Immunol; 2024; 15():1457691. PubMed ID: 39301023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive multi-omics analysis reveals a combination of lncRNAs that synergistically regulate glycolysis and immunotherapeutic effects in renal clear cell carcinoma.
    Li Y; Hou B; Xu Y; Li H; Zhu Y; Kong C
    Aging (Albany NY); 2024 Aug; 16(16):11955-11969. PubMed ID: 39167430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of biomarkers related to CD8
    Lin J; Yu M; Xu X; Wang Y; Xing H; An J; Yang J; Tang C; Sun D; Zhu Y
    Aging (Albany NY); 2020 Feb; 12(4):3694-3712. PubMed ID: 32081834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
    Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H
    Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy.
    Bai D; Feng H; Yang J; Yin A; Qian A; Sugiyama H
    Cancer Sci; 2021 Jun; 112(6):2126-2139. PubMed ID: 33735492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact and immunotherapeutic implications of NETosis-related prognostic model in clear cell renal cell carcinoma.
    Mao X; Huang W; Xue Q; Zhang X
    J Cancer Res Clin Oncol; 2024 May; 150(5):278. PubMed ID: 38801430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The JAK-STAT signaling-related signature serves as a prognostic and predictive biomarker for renal cell carcinoma immunotherapy.
    Chan S; Liu Z; Chen Y; Chen S; Liang Y; Yang Z; Zhang Z; Li M; Zhang X; Liu X
    Gene; 2024 Nov; 927():148719. PubMed ID: 38917875
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Gong X; Liu Y; Zhang Q; Liang K; Wei J; Du H
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troponin T1 in tumorigenesis and immune modulation: Insights into multiple cancers and kidney renal clear cell carcinoma.
    Zhang Q; Hao L; Wang F; Yu Q; Wu S; Han C
    J Cell Mol Med; 2024 Jun; 28(11):e18410. PubMed ID: 38853457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma.
    Wei B; Yu M; Yao J; Jiang M; An J; Yang J; Lin J; Zhao Y; Zhu Y
    Front Immunol; 2021; 12():657951. PubMed ID: 34531849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
    Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
    Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
    [No Abstract]   [Full Text] [Related]  

  • 17. Exosome-related lncRNA score: A value-based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma.
    Yang Z; Zhang X; Zhan N; Lin L; Zhang J; Peng L; Qiu T; Luo Y; Liu C; Pan C; Hu J; Ye Y; Jiang Z; Liu X; Sun M; Zhang Y
    Cancer Med; 2024 Jun; 13(11):e7308. PubMed ID: 38808948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHC1 serves as a prognostic and immunological biomarker in clear cell renal cell carcinoma: a comprehensive bioinformatics and experimental analysis.
    Guo Z; Cai C; Zhou K; Song L; Wang X; Chen D; Weng G; Huang S
    Sci Rep; 2024 Aug; 14(1):20150. PubMed ID: 39209911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.
    Li K; Liu J; Yang X; Tu Z; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34762107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.